Cytoskeletal protein degradation in brain death donor kidneys associates with adverse posttransplant outcomes

Cytoskeletal protein degradation in brain death donor kidneys associates with adverse posttransplant outcomes

In brain death, cerebral injury contributes to systemic biological dysregulation, causing significant cellular stress in donor kidneys adversely impacting the quality of grafts. Here, we hypothesized that donation after brain death (DBD) kidneys undergo proteolytic processes that may deem grafts sus...

Descripció completa

Dades bibliogràfiques
Autors principals:	Vaughan, RH, Kresse, J-C, Farmer, LK, Thézénas, ML, Kessler, BM, Lindeman, JHN, Sharples, EJ, Welsh, GI, Nørregaard, R, Ploeg, RJ, Kaisar, ME
Format:	Journal article
Idioma:	English
Publicat:	Wiley 2022

Ítems similars

Predicting clinical endpoints and visual changes with quality-weighted tissue-based renal histological features
per: Tam, KH, et al.
Publicat: (2024)

Transplant and recipient factors in prediction of kidney transplant outcomes: a UK-wide paired analysis
per: Dumbill, R, et al.
Publicat: (2022)

THE EFFECT OF NORMOTHERMIC RECIRCULATION BEFORE COLD PRESERVATION ON POSTTRANSPLANT INJURY OF ISCHEMICALLY DAMAGED DONOR KIDNEYS
per: Moers, C, et al.
Publicat: (2011)

Plasma biomarker profile alterations during variable blood storage
per: Kaisar, M, et al.
Publicat: (2016)

Using established biorepositories for emerging research questions: a feasibility study
per: Lerink, LJS, et al.
Publicat: (2024)

Posttransplant Metabolic Syndrome
per: M. Shadab Siddiqui, et al.
Publicat: (2012-01-01)

Posttransplant Intrarenal Lymphangiectasia
per: Ali Kord, et al.
Publicat: (2020-01-01)

Posttransplant Lymphoproliferative Disorders
per: Hazem A. H. Ibrahim, et al.
Publicat: (2012-01-01)

Posttransplant Immune Activation
per: Didier Ducloux, et al.
Publicat: (2017-09-01)

Donor characteristics and their impact on kidney transplantation outcomes: results from two nationwide instrumental variable analyses based on outcomes of donor kidney pairs accepted for transplantation
per: Schaapherder, AF, et al.
Publicat: (2022)

Kidney tissue proteome profiles in short versus long duration of delayed graft function – a pilot study in donation after circulatory death donors
per: Lo Faro, ML, et al.
Publicat: (2024)

An Unusual Immediate Posttransplant Eruption
per: Ravi K. Mallavarapu, et al.
Publicat: (2025-02-01)

The prognostic value of posttransplant chimerism
per: A. A. Sipol, et al.
Publicat: (2022-11-01)

Renal posttransplant's vascular complications
per: Bašić Dragoslav, et al.
Publicat: (2003-01-01)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
per: Brendan L. Mangan, et al.
Publicat: (2020-11-01)

Subclinical changes in deceased donor kidney proteomes are associated with 12-month allograft function post transplantation: A preliminary study
per: Kaisar, M, et al.
Publicat: (2018)

A case of posttransplant lymphoproliferative disorder
per: G S Chowdhary, et al.
Publicat: (2017-01-01)

Identification of Cause of Posttransplant Cachexia by PCR
per: Joelle Guitard, et al.
Publicat: (2012-08-01)

Early posttransplant granulomatous interstitial nephritis
per: Sriram Sriperumbuduri, et al.
Publicat: (2017-01-01)

The role of flavin mononucleotide (FMN) as a potentially clinically relevant biomarker to predict the quality of kidney grafts during hypothermic (oxygenated) machine perfusion
per: van de Leemkolk, FEM, et al.
Publicat: (2023)

Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass
per: Reuben J. Arasaratnam, et al.
Publicat: (2017-01-01)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
per: Andrea Bacigalupo, et al.
Publicat: (2016-01-01)

Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes
per: Simon Bøtker, et al.
Publicat: (2023-01-01)

Posttransplant complications: molecular mechanisms and therapeutic interventions
per: Xiaoyou Liu, et al.
Publicat: (2024-09-01)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
per: Isabel P. Neuringer
Publicat: (2013-01-01)

Posttransplant thrombotic microangiopathy: Unraveling a mystery
per: Mohammed Fahad Khan, et al.
Publicat: (2024-01-01)

Posttransplant thrombotic microangiopathy: Unraveling a mystery
per: Mohammed Fahad Khan, et al.
Publicat: (2024-01-01)

Percutaneous Nephrostomy for Treatment of Posttransplant Ureteral Obstructions
per: Mohammad Hossein Nourbala, et al.
Publicat: (2008-06-01)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
per: Thanh-Phuong Afiat, et al.
Publicat: (2018-01-01)

Posttransplant vesical calculi – A case series
per: Dimple Kumar Chanamolu, et al.
Publicat: (2019-01-01)

Posttransplant membranous nephropathy - A case report
per: Shabna Sullaiman, et al.
Publicat: (2022-01-01)

Urinary calprotectin and posttransplant renal allograft injury.
per: Martin Tepel, et al.
Publicat: (2014-01-01)

Posttransplant thrombotic microangiopathy: A rare cause
per: Chaitanya Siva Marupudi, et al.
Publicat: (2020-01-01)

Plasma degradome affected by variable storage of human blood
per: Kaisar, M, et al.
Publicat: (2016)

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
per: Chen, Jianzhu
Publicat: (2022)

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
per: Roman M. Shapiro, et al.
Publicat: (2022-06-01)

COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
per: Rivinius R, et al.
Publicat: (2018-09-01)

Cytoskeletal Proteins of Actinobacteria
per: Michal Letek, et al.
Publicat: (2012-01-01)

Cytoskeletal Remodeling in Cancer
per: Jaya Aseervatham
Publicat: (2020-11-01)

Cytoskeletal Tensegrity in Microgravity
per: John Gardiner
Publicat: (2021-10-01)